Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVESteven Grinspoon, Pamela S. Douglas, Triin Umbleja et al.|The Lancet HIV|2025Cited by 32
Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender SpectrumLaura Smeaton, Karin L. Klingman, Emma M. Kileel et al.|The Journal of Infectious Diseases|2020Cited by 6